Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

In Vivo Magnetic Resonance Imaging Of Cell Tropism, Trafficking Mechanism, And Therapeutic Impact Of Human Mesenchymal Stem Cells In A Murine Glioma Model.

Li-Ying Chien, Jong-Kai Hsiao, Szu-Chun Hsu, M. Yao, Chen-Wen Lu, Hon-Man Liu, Yao-Chang Chen, C. Yang, D. Huang
Published 2011 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Stem cells have offered much promise as delivery vehicles for brain tumor therapy, with the development of modalities to track the tumor tropism of stem cells receiving intense focus. Cellular magnetic resonance imaging (MRI) allows serial high-resolution in vivo detection of transplanted stem cells' tropism toward gliomas in the mouse brain once these cells are internally labeled with iron oxide particles, but has been impeded by low labeling efficiencies. In this study, we describe the use of ferucarbotran and protamine (Fer-Pro) complexes for labeling human mesenchymal stem cells (hMSCs) for MRI tracking of glioma tropism in vivo. We found that Fer-Pro was not toxic and was highly efficient for labeling in vitro. Cell labeling with Fer-Pro promoted the migration of hMSCs toward glioma U87MG cells in vitro, which was mediated by stromal-derived factor-1/CXCR4 (SDF-1/CXCR4) signaling. Fer-Pro-labeled hMSCs could migrate specifically toward gliomas in vivo, which was observed with a clinical 1.5-T MRI system. The efficient labeling of Fer-Pro also allowed a tropic mechanism mediated by SDF-1/CXCR4 signaling to be detected by MRI in vivo. Additionally, the potential intrinsic inhibitory effect of hMSCs on glioma progression was estimated simultaneously. This is the first report to have used a clinical MRI modality to simultaneously study the migration, the therapeutic impact on tumors, and above all the trafficking mechanism of bone marrow-derived mesenchymal stem cells from human in a murine glioma xenograft model. The use of Fer-Pro for stem cell labeling may have potential clinical applications in stem cell guided therapy.
This paper references
10.1096/fj.05-4288fje
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking
D. Huang (2005)
10.1002/mrm.21642
Serial in vivo positive contrast MRI of iron oxide‐labeled embryonic stem cell‐derived cardiac precursor cells in a mouse model of myocardial infarction
V. Mani (2008)
Low and high molecular weight poly(L-lysine)s/poly(L-lysine)-DNA complexes initiate mitochondrial-mediated apoptosis
P Symonds (2005)
10.1158/0008-5472.CAN-04-1874
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
A. Nakamizo (2005)
Targeted therapy for malignant: neural stem cells
MS Lesniak (2006)
10.1182/BLOOD-2004-02-0655
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.
A. Arbab (2004)
10.1586/14737175.6.1.1
Targeted therapy for malignant glioma: neural stem cells
M. Lesniak (2006)
10.1158/0008-5472.CAN-03-1246
Neural Progenitor Cell Lines Inhibit Rat Tumor Growth in Vivo
K. Staflin (2004)
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001;19:180e92
P Bianco (2001)
Low and high molecular weight poly ( L - lysine ) s / poly ( L - lysine )DNA complexes initiate mitochondrialmediated apoptosis differently
P Symonds (2006)
10.1038/cr.2008.40
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
L. Qiao (2008)
10.1126/SCIENCE.284.5411.143
Multilineage potential of adult human mesenchymal stem cells.
M. Pittenger (1999)
: nature , biology , and potential applications
P Bianco (1987)
10.1016/j.febslet.2005.09.092
Low and high molecular weight poly(l‐lysine)s/poly(l‐lysine)–DNA complexes initiate mitochondrial‐mediated apoptosis differently
P. Symonds (2005)
CellularmultiparametricMRI of neural stemcell therapy in a rat gliomamodel
C Brekke (2007)
10.1016/S0002-9440(10)61750-6
Glioma classification: a molecular reappraisal.
D. Louis (2001)
10.1038/74464
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
M. Lewin (2000)
10.1126/SCIENCE.297.5579.175A
Stem Cells Not So Stealthy After All
G. Vogel (2002)
10.2217/17460751.3.6.807
Use of ferumoxides for stem cell labeling.
H. Sadek (2008)
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling of with ferumoxides. Blood 2004;104:3410e2
JWM Bulte (2004)
10.1002/NBM.991
Labeling of cells with ferumoxides–protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells
A. Arbab (2005)
10.1007/s00330-009-1585-1
Accelerated stem cell labeling with ferucarbotran and protamine
Daniel Golovko (2009)
10.1021/BC980125H
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates.
L. Josephson (1999)
10.1111/j.1365-2184.1987.tb01309.x
Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers
A. Friedenstein (1987)
10.1007/s00330-004-2405-2
Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
S. Metz (2004)
10.1053/J.SEMINONCOL.2004.07.005
Current management of glioblastoma multiforme.
S. Grossman (2004)
10.1038/sj.gt.3302276
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
K. Nakamura (2004)
10.1016/J.ADDR.2006.09.008
Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.
A. C. Hunter (2006)
Molecularhurdles inpolyfectiondesignandmechanisticbackground to polycation induced cytotoxicity
HunterAC (2005)
10.1016/j.biomaterials.2009.03.032
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles.
D. Huang (2009)
10.1182/BLOOD-2004-06-2117
Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides.
J. Bulte (2004)
10.1002/mrm.20701
Instant MR labeling of stem cells using magnetoelectroporation
P. Walczak (2005)
10.1084/jem.20051921
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
A. Khakoo (2006)
Embryonic stem cells. Stem cells not so stealthy after all.
G. Vogel (2002)
10.1016/j.neuroimage.2004.05.019
In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor
Z. Zhang (2004)
10.1073/PNAS.97.23.12846
Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
K. S. Aboody (2000)
10.1016/j.taap.2010.03.011
The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells.
Ying-chun Chen (2010)
10.1634/stemcells.19-3-180
Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential Applications
P. Bianco (2001)
10.1007/s11307-007-0130-3
Carboxylated Superparamagnetic Iron Oxide Particles Label Cells Intracellularly Without Transfection Agents
V. Mailänder (2007)
10.1016/j.neuroimage.2007.06.006
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model
C. Brekke (2007)
10.1371/journal.pone.0007218
Iron Labeling and Pre-Clinical MRI Visualization of Therapeutic Human Neural Stem Cells in a Murine Glioma Model
Mya S. Thu (2009)
10.1016/J.BIOMATERIALS.2004.05.022
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
A. Gupta (2005)
10.1158/0008-5472.CAN-04-1337
Genetic Pathways to Glioblastoma
H. Ohgaki (2004)
10.1002/mrm.21377
Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: Cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level
J. Hsiao (2007)
10.1038/SJ.THJ.6200232
Mesenchymal stem cell: use and perspectives.
A. Tocci (2003)
10.3171/FOC.2005.19.3.6
Stem cell therapies for malignant glioma.
M. Ehtesham (2005)
10.1634/stemcells.2007-0758
Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
A. Sonabend (2008)
10.1038/74710
Gene therapy of experimental brain tumors using neural progenitor cells
S. Benedetti (2000)
10.1212/WNL.35.2.219
Epidemiology of brain tumors
A. Walker (1985)
10.1016/S0022-5223(19)41500-6
Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
B. Bull (1975)
10.1016/S0142-9612(02)00440-4
Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating.
C. Wilhelm (2003)
10.1593/neo.03427
Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.
M. Ehtesham (2004)



This paper is referenced by
10.1021/nn2033902
Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy.
Tsai-Hua Chung (2011)
10.5772/34252
Magnetic Nanoparticles: Its Effect on Cellular Behaviour and Potential Applications
H. Liu (2012)
10.1039/C6RA03453E
Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs
Tsai-Hua Chung (2016)
10.1016/j.biomaterials.2012.03.047
Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles.
C. Wang (2012)
10.1016/j.biochi.2018.07.008
The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas.
E. D. Gomes (2018)
10.1155/2013/764095
The mutual beneficial effect between medical imaging and nanomedicine
Huiting Qiao (2013)
10.1007/s11060-011-0754-7
Imaging of human mesenchymal stromal cells: homing to human brain tumors
L. Menon (2011)
10.3390/nano8100761
The Impact of Metallic Nanoparticles on Stem Cell Proliferation and Differentiation
Ahmed Abdal Dayem (2018)
10.1128/JVI.05318-11
Identification of Chemoattractive Factors Involved in the Migration of Bone Marrow-Derived Mesenchymal Stem Cells to Brain Lesions Caused by Prions
C.-H. Song (2011)
10.1002/PPSC.201300199
Stem Cell Labeling and Tracking with Nanoparticles
C. Liang (2013)
10.1002/smll.201301673
Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.
Xihui Gao (2014)
10.2147/IJN.S278687
Bidirectional Enhancement of Cell Proliferation Between Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cells and Choroid Plexus in a Cell-Based Therapy Model of Ischemic Stroke
Menq-Rong Wu (2020)
10.1038/s41467-018-07250-6
MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma
M. Wu (2018)
10.1016/B978-0-12-803102-5.00007-0
Mesenchymal Stem/Stromal Cell Trafficking and Homing
A. H. N. Kamdje (2016)
10.5966/sctm.2013-0049
Magnetic Resonance Imaging Tracking of Ferumoxytol‐Labeled Human Neural Stem Cells: Studies Leading to Clinical Use
M. Gutova (2013)
10.5772/17821
Clinical Stem Cell Imaging and In vivo Tracking
S. Mirpour (2011)
10.1371/journal.pone.0110142
Novel Positively Charged Nanoparticle Labeling for In Vivo Imaging of Adipose Tissue-Derived Stem Cells
H. Yukawa (2014)
10.1002/anie.201302245
Multimodal magnetic core-shell nanoparticles for effective stem-cell differentiation and imaging.
B. Shah (2013)
10.1007/s12975-011-0098-9
Validity of Bone Marrow Stromal Cell Expansion by Animal Serum-Free Medium for Cell Transplantation Therapy of Cerebral Infarct in Rats—A Serial MRI Study
M. Ito (2011)
10.1186/s12951-015-0080-x
Superparamagnetic core/shell GoldMag nanoparticles: size-, concentration- and time-dependent cellular nanotoxicity on human umbilical vein endothelial cells and the suitable conditions for magnetic resonance imaging
Mingfu Gong (2015)
10.4172/2157-2518.1000291
Development of Anti-Cancer Stem Cells as Theranostic Agents in the Treatment of Different Cancer Types: An Update
A. Malik (2017)
10.1039/c8nr00703a
A unique 19F MRI agent for the tracking of non phagocytic cells in vivo.
S. Moonshi (2018)
10.1098/rsos.191561
Cytotoxicity studies of Fe3O4 nanoparticles in chicken macrophage cells
S. Zhang (2020)
10.1002/mrm.27749
In vivo imaging of insulin‐secreting human pancreatic ductal cells using MRI reporter gene technique: A feasibility study
Menq-Rong Wu (2019)
Estudo de internalização e viabilidade de nanopartículas multimodal para marcação de células-tronco mesenquimais de cordão umbilical humano Study of internalization and viability of multimodal nanoparticles for labeling of human umbilical cord mesenchymal stem cells
Liza Aya (2012)
10.1039/c3ib40165k
Nanoparticles and their applications in cell and molecular biology.
E. Wang (2014)
10.1101/665315
Precise implantation of super-paramagnetic iron oxide (SPIO) nanoparticles in hippocampus with external rotating magnetic field (RMF) produces rapid antidepressent effects in mice
Yao Chi (2019)
10.1515/ejnm-2015-0024
Inorganic nanoparticles for the theranostics of cancer
Jyoti Verma (2015)
10.4103/0366-6999.226900
Imaging Gliomas with Nanoparticle-Labeled Stem Cells
Shuang-Lin Deng (2018)
16 Magnetic Nanoparticles : Its Effect on Cellular Behaviour and Potential Applications
H. Liu (2018)
10.1016/j.drudis.2013.06.004
Molecular imaging in the development of a novel treatment paradigm for glioblastoma (GBM): an integrated multidisciplinary commentary.
M. Jarzabek (2013)
10.1016/j.biopha.2015.08.035
Identification of valid endogenous control genes for determining gene expression in C6 glioma cell line treated with conditioned medium from adipose-derived stem cell.
I.C. Iser (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar